Pfizer Limited has informed the Exchange about change in Management
PFIZER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Pfizer Limited has informed the exchange of two senior management changes. Mr. Deepak Rakheja, who led Strategic Partnerships, Channel Development and International Neighbouring Markets, has resigned effective close of business on July 8, 2026, to pursue opportunities outside Pfizer. Separately, Mr. Anil Pattanshetty, Senior Director of Business Operations, will transition to another Pfizer Group company from April 1, 2026, and will cease to be a Senior Management Personnel of Pfizer Limited with effect from March 31, 2026 (close of business). Both changes are routine, with no operational disruption indicated.
One departure is an external exit and the other is an internal group-level transfer within the Pfizer network — neither suggests governance concerns and is unlikely to materially affect the stock price or shareholder value.